| Income Statement |
| Total Revenue | 33.80M |
|
| Revenues (USD) | 33.80M |
| Cost of Revenue | 23.09M |
| Gross Profit | 10.71M |
| Operating Expenses | 6.47M |
| Research and Development Expense | 629.00K |
| Selling, General and Administrative Expense | 5.84M |
| Operating Income | 4.24M |
| Income Tax Expense | 1.33M |
| Net Income | 3.84M |
| Net Income Common Stock | 3.84M |
| Net Income Common Stock (USD) | 3.84M |
| Consolidated Income | 3.84M |
| Earnings per Basic Share | 0.26 |
| Earnings per Basic Share (USD) | 0.26 |
| Earnings per Diluted Share | 0.26 |
| Earning Before Interest & Taxes (EBIT) | 5.17M |
| Earning Before Interest & Taxes (USD) | 5.17M |
| Weighted Average Shares | 14.66M |
| Balance Sheet |
| Cash and Equivalents | 43.46M |
| Cash and Equivalents (USD) | 43.46M |
| Investments | 111.67M |
| Investments Current | 111.67M |
| Trade and Non-Trade Receivables | 3.93M |
| Current Assets | 220.86M |
| Property, Plant & Equipment Net | 11.15M |
| Total Assets | 237.06M |
| Debt Current | 156.00K |
| Total Debt | 156.00K |
| Current Liabilities | 15.61M |
| Total Liabilities | 17.98M |
| Accumulated Retained Earnings (Deficit) | 205.03M |
| Shareholders Equity | 219.09M |
| Shareholders Equity (USD) | 219.09M |
| Assets Non-Current | 16.21M |
| Total Debt (USD) | 156.00K |
| Deferred Revenue | 1.23M |
| Deposit Liabilities | 7.11M |
| Inventory | 51.07M |
| Liabilities Non-Current | 2.37M |
| Trade and Non-Trade Payables | 4.83M |
| Tax Assets | 4.84M |
| Tax Liabilities | 2.37M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 529.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | 6.73M |
| Capital Expenditure | -179.00K |
| Net Cash Flow from Investing | -179.00K |
| Net Cash Flow from Operations | 6.91M |